Open-mkt buys · 90d
$20.1K
2 trades · 1 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$20.1K
Insiders on file
28
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Grossman William | Interim Chief Medical Officer, Director | 5 | $20.1K | $0 | 2026-09-22 |
| Joustra Wouter | Director | 3 | $0 | $0 | 2026-06-16 |
| Heffernan Michael Thomas | Director | 2 | $0 | $0 | 2026-06-16 |
| BRUNK GERALD A | Director, 10% Owner | 17 | $0 | $0 | 2026-06-16 |
| Astley-Sparke Philip | Director | 2 | $0 | $0 | 2026-06-16 |
| Glickman Richard M | Director | 14 | $0 | $0 | 2026-06-16 |
| HASTINGS PAUL J | Director | 3 | $0 | $0 | 2026-06-16 |
| Zoth Lota S. | Director | 4 | $0 | $0 | 2026-06-16 |
| Boyd Matthew Ross | Chief Regulatory Officer | 2 | $0 | $0 | 2026-01-30 |
| Connolly Joan | Chief Technology Officer | 2 | $0 | $0 | 2026-01-30 |
| Nichols Alexander Julian | Pres. & Chief Operating Ofc. | 4 | $0 | $0 | 2026-01-30 |
| CHEUNG ANTHONY TZEYEW | Chief Technology Officer | 14 | $0 | $0 | 2026-01-30 |
| Giguere Lee | Chief Legal Ofc. and Corp Secy | 3 | $0 | $0 | 2026-01-30 |
| Buck Jill | Chief Development Officer | 2 | $0 | $0 | 2026-01-30 |
| Cooper Ronald Harold Wilfred | Chief Executive Officer | 4 | $57.0K | $0 | 2026-01-30 |
| Daws D. Ryan | Chief Financial Officer | 3 | $0 | $0 | 2026-01-30 |
| Sweiti Hussein | Chief Medical Officer | 1 | $0 | $0 | 2025-09-30 |
| Bos Jasper | Director | 2 | $0 | $0 | 2025-06-16 |
| Pott Amy | Chief Global Comm. Ofc. | 1 | $0 | $0 | 2025-06-16 |
| Pruthi Raj Som | Chief Medical Officer | 2 | $0 | $0 | 2025-01-29 |
| Forbion Growth Management B.V. | 10% Owner | 1 | $5.00M | $0 | 2024-10-30 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | 13 | $3.01M | $0 | 2024-10-08 |
| FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10% Owner | 3 | $0 | $788.0K | 2024-04-22 |
| Lumira Capital Investment Management Inc. | 10% Owner | 2 | $0 | $0 | 2024-02-20 |
| BRYCE RICHARD PAUL | Chief Medical Officer | 1 | $0 | $0 | 2023-11-30 |
| Forbion Growth Sponsor FEAC I B.V. | 10% Owner | 4 | $0 | $0 | 2023-10-31 |
| Sullivan James Crowley | Chief Scientific Officer | 2 | $0 | $0 | 2023-07-07 |
| Hanson Jason David | Chief Executive Officer | 5 | $0 | $0 | 2023-07-07 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Grossman William | Interim Chief Medical Office | P Buy | 2026-09-22 | 2026-09-24 | 5,102 | $1.97 | $10.1K | 5,102 | SEC↗ |
| Grossman William | Interim Chief Medical Office | P Buy | 2026-09-22 | 2026-09-24 | 5,102 | $1.97 | $10.1K | 5,102 | SEC↗ |
| Zoth Lota S. | Director | A Award deriv | 2026-06-16 | 2026-06-17 | 31,000 | — | $0 | 31,000 | SEC↗ |
| Joustra Wouter | Director | A Award deriv | 2026-06-16 | 2026-06-17 | 31,000 | — | $0 | 31,000 | SEC↗ |
| Heffernan Michael Thomas | Director | A Award deriv | 2026-06-16 | 2026-06-17 | 31,000 | — | $0 | 31,000 | SEC↗ |
| HASTINGS PAUL J | Director | A Award deriv | 2026-06-16 | 2026-06-17 | 31,000 | — | $0 | 31,000 | SEC↗ |
| Grossman William | Interim Chief Medical Office | A Award deriv | 2026-06-16 | 2026-06-17 | 31,000 | — | $0 | 31,000 | SEC↗ |
| Grossman William | Interim Chief Medical Office | A Award deriv | 2026-06-16 | 2026-06-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Glickman Richard M | Director | A Award deriv | 2026-06-16 | 2026-06-17 | 31,000 | — | $0 | 31,000 | SEC↗ |
| BRUNK GERALD A | Director | A Award deriv | 2026-06-16 | 2026-06-17 | 31,000 | — | $0 | 31,000 | SEC↗ |
| Astley-Sparke Philip | Director | A Award deriv | 2026-06-16 | 2026-06-17 | 31,000 | — | $0 | 31,000 | SEC↗ |
| Buck Jill | Chief Development Officer | A Award deriv | 2026-01-30 | 2026-02-03 | 195,000 | — | $0 | 195,000 | SEC↗ |
| Boyd Matthew Ross | Chief Regulatory Officer | A Award deriv | 2026-01-30 | 2026-02-03 | 195,000 | — | $0 | 195,000 | SEC↗ |
| Connolly Joan | Chief Technology Officer | A Award deriv | 2026-01-30 | 2026-02-03 | 195,000 | — | $0 | 195,000 | SEC↗ |
| Cooper Ronald Harold Wilfred | CEO & President | A Award deriv | 2026-01-30 | 2026-02-03 | 801,000 | — | $0 | 801,000 | SEC↗ |
| Daws D. Ryan | Chief Financial Officer | A Award deriv | 2026-01-30 | 2026-02-03 | 220,000 | — | $0 | 220,000 | SEC↗ |
| Nichols Alexander Julian | Chief Strategy & Ops. Ofc | A Award deriv | 2026-01-30 | 2026-02-03 | 195,000 | — | $0 | 195,000 | SEC↗ |
| Giguere Lee | Chief Legal Ofc. and Corp Se | A Award deriv | 2026-01-30 | 2026-02-03 | 195,000 | — | $0 | 195,000 | SEC↗ |
| CHEUNG ANTHONY TZEYEW | Chief Scientific Officer | A Award deriv | 2026-01-30 | 2026-02-03 | 195,000 | — | $0 | 195,000 | SEC↗ |
| Sweiti Hussein | Chief Medical Officer | A Award deriv | 2025-09-30 | 2025-10-01 | 600,000 | — | $0 | 600,000 | SEC↗ |
| Buck Jill | Chief Development Officer | A Award deriv | 2025-07-08 | 2025-07-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Grossman William | Director | A Award deriv | 2025-07-08 | 2025-07-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Heffernan Michael Thomas | Director | A Award deriv | 2025-07-08 | 2025-07-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Astley-Sparke Philip | Director | A Award deriv | 2025-07-08 | 2025-07-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Boyd Matthew Ross | Chief Regulatory Officer | A Award deriv | 2025-07-08 | 2025-07-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Bos Jasper | Director | A Award deriv | 2025-06-16 | 2025-06-16 | 22,500 | — | $0 | 22,500 | SEC↗ |
| BRUNK GERALD A | Director | A Award deriv | 2025-06-16 | 2025-06-16 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Glickman Richard M | Director | A Award deriv | 2025-06-16 | 2025-06-16 | 22,500 | — | $0 | 22,500 | SEC↗ |
| HASTINGS PAUL J | Director | A Award deriv | 2025-06-16 | 2025-06-16 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Joustra Wouter | Director | A Award deriv | 2025-06-16 | 2025-06-16 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Pott Amy | Chief Global Comm. Ofc. | A Award deriv | 2025-06-16 | 2025-06-16 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Zoth Lota S. | Director | A Award deriv | 2025-06-16 | 2025-06-16 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Cooper Ronald Harold Wilfred | CEO & President | A Award deriv | 2025-01-29 | 2025-01-31 | 850,000 | — | $0 | 850,000 | SEC↗ |
| CHEUNG ANTHONY TZEYEW | Chief Scientific Officer | A Award deriv | 2025-01-29 | 2025-01-31 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Daws D. Ryan | Chief Financial Officer | A Award deriv | 2025-01-29 | 2025-01-31 | 280,000 | — | $0 | 280,000 | SEC↗ |
| Giguere Lee | Chief Legal Ofc. and Corp Se | A Award deriv | 2025-01-29 | 2025-01-31 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Nichols Alexander Julian | Chief Strategy & Ops. Ofc | A Award deriv | 2025-01-29 | 2025-01-31 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Pruthi Raj Som | Chief Medical Officer | A Award deriv | 2025-01-29 | 2025-01-31 | 280,000 | — | $0 | 280,000 | SEC↗ |
| Forbion Growth Management B.V. | 10% Owner | P Buy | 2024-10-30 | 2024-11-01 | 561,797 | $8.90 | $5.00M | 3,032,430 | SEC↗ |
| Connolly Joan | Chief Technology Officer | A Award deriv | 2024-10-21 | 2024-10-22 | 210,000 | — | $0 | 210,000 | SEC↗ |
| CHEUNG ANTHONY TZEYEW | Chief Scientific Officer | A Award deriv | 2024-10-21 | 2024-10-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Forbion Growth Opportunities F | 10% Owner | P Buy | 2024-10-08 | 2024-10-18 | 800 | $6.60 | $5.3K | 2,470,633 | SEC↗ |
| Forbion Growth Opportunities F | 10% Owner | P Buy | 2024-10-07 | 2024-10-18 | 11,844 | $6.55 | $77.6K | 2,469,833 | SEC↗ |
| Forbion Growth Opportunities F | 10% Owner | P Buy | 2024-10-04 | 2024-10-18 | 5,997 | $6.54 | $39.2K | 2,457,989 | SEC↗ |
| Forbion Growth Opportunities F | 10% Owner | P Buy | 2024-10-03 | 2024-10-18 | 5,769 | $6.48 | $37.4K | 2,451,992 | SEC↗ |
| Forbion Growth Opportunities F | 10% Owner | P Buy | 2024-10-02 | 2024-10-18 | 10,153 | $6.37 | $64.7K | 2,446,223 | SEC↗ |
| Forbion Growth Opportunities F | 10% Owner | P Buy | 2024-10-01 | 2024-10-18 | 35,279 | $6.44 | $227.2K | 2,436,070 | SEC↗ |
| Forbion Growth Opportunities F | 10% Owner | P Buy | 2024-09-30 | 2024-10-18 | 341,332 | $6.34 | $2.16M | 2,400,791 | SEC↗ |
| Cooper Ronald Harold Wilfred | Chief Executive Officer | P Buy | 2024-09-27 | 2024-10-01 | 10,000 | $5.70 | $57.0K | 10,000 | SEC↗ |
| Forbion Growth Opportunities F | 10% Owner | P Buy | 2024-09-27 | 2024-10-18 | 3,243 | $6.38 | $20.7K | 2,059,459 | SEC↗ |
| Forbion Growth Opportunities F | 10% Owner | P Buy | 2024-09-27 | 2024-10-18 | 38,396 | $5.94 | $228.1K | 2,056,216 | SEC↗ |
| Pruthi Raj Som | Chief Medical Officer | A Award deriv | 2024-07-24 | 2024-07-25 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Cooper Ronald Harold Wilfred | Chief Executive Officer | A Award deriv | 2024-07-22 | 2024-07-24 | 1,250,000 | — | $0 | 1,250,000 | SEC↗ |
| BRUNK GERALD A | Director | A Award deriv | 2024-06-15 | 2024-06-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Bos Jasper | Director | A Award deriv | 2024-06-15 | 2024-06-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Glickman Richard M | Director | A Award deriv | 2024-06-15 | 2024-06-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Joustra Wouter | Director | A Award deriv | 2024-06-15 | 2024-06-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| HASTINGS PAUL J | Director | A Award deriv | 2024-06-15 | 2024-06-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Zoth Lota S. | Director | A Award deriv | 2024-06-15 | 2024-06-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Glickman Richard M | Director | M Exercise deriv | 2024-05-28 | 2024-05-29 | 120 | — | $0 | 0 | SEC↗ |
| Glickman Richard M | Director | M Exercise | 2024-05-28 | 2024-05-29 | 120 | $0.89 | $107 | 24,675 | SEC↗ |
| FONDS DE SOLIDARITE DES TRAVAI | 10% Owner | S Sale | 2024-04-22 | 2024-04-22 | 47,854 | $15.00 | $717.8K | 3,036,153 | SEC↗ |
| FONDS DE SOLIDARITE DES TRAVAI | 10% Owner | S Sale | 2024-04-19 | 2024-04-22 | 100 | $15.00 | $1.5K | 3,084,007 | SEC↗ |
| FONDS DE SOLIDARITE DES TRAVAI | 10% Owner | S Sale | 2024-04-18 | 2024-04-22 | 4,575 | $15.01 | $68.7K | 3,084,107 | SEC↗ |
| Zoth Lota S. | Director | A Award deriv | 2024-03-21 | 2024-03-25 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CHEUNG ANTHONY TZEYEW | Chief Technology Officer | M Exercise deriv | 2024-03-18 | 2024-03-20 | 52,940 | — | $0 | 0 | SEC↗ |
| CHEUNG ANTHONY TZEYEW | Chief Technology Officer | M Exercise | 2024-03-18 | 2024-03-20 | 52,940 | $0.89 | $47.1K | 102,873 | SEC↗ |
| Giguere Lee | Chief Legal Ofc. and Corp Se | A Award deriv | 2024-03-15 | 2024-03-19 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Lumira Capital Investment Mana | 10% Owner | A Award | 2024-02-20 | 2024-02-21 | 644,965 | $10.00 | $6.45M | 993,651 | SEC↗ |
| Lumira Capital Investment Mana | 10% Owner | A Award | 2024-02-20 | 2024-02-21 | 155,035 | $10.00 | $1.55M | 238,851 | SEC↗ |
| BRUNK GERALD A | Director, 10% Owner | A Award | 2024-02-20 | 2024-02-21 | 155,035 | $10.00 | $1.55M | 238,851 | SEC↗ |
| BRUNK GERALD A | Director, 10% Owner | A Award | 2024-02-20 | 2024-02-21 | 644,965 | $10.00 | $6.45M | 993,651 | SEC↗ |
| Forbion Growth Opportunities F | 10% Owner | P Buy | 2023-12-29 | 2024-10-18 | 9,620 | $9.09 | $87.4K | 2,017,820 | SEC↗ |
| Forbion Growth Opportunities F | 10% Owner | P Buy | 2023-12-29 | 2024-10-18 | 400 | $8.30 | $3.3K | 2,008,200 | SEC↗ |
| Forbion Growth Opportunities F | 10% Owner | P Buy | 2023-12-28 | 2024-10-18 | 5,050 | $7.69 | $38.8K | 2,007,800 | SEC↗ |
| Forbion Growth Opportunities F | 10% Owner | P Buy | 2023-12-27 | 2024-10-18 | 2,750 | $7.17 | $19.7K | 2,002,750 | SEC↗ |
| Daws D. Ryan | Chief Financial Officer | A Award deriv | 2023-11-30 | 2023-12-04 | 232,000 | — | $0 | 232,000 | SEC↗ |
| BRYCE RICHARD PAUL | Chief Medical Officer | A Award deriv | 2023-11-30 | 2023-12-04 | 153,000 | — | $0 | 153,000 | SEC↗ |
| BRUNK GERALD A | Director, 10% Owner | A Award deriv | 2023-10-31 | 2023-11-02 | 20,673 | — | $0 | 20,673 | SEC↗ |
| BRUNK GERALD A | Director, 10% Owner | A Award deriv | 2023-10-31 | 2023-11-02 | 3,825 | — | $0 | 3,825 | SEC↗ |
| BRUNK GERALD A | Director, 10% Owner | A Award deriv | 2023-10-31 | 2023-11-02 | 38,301 | — | $0 | 38,301 | SEC↗ |
| BRUNK GERALD A | Director, 10% Owner | A Award deriv | 2023-10-31 | 2023-11-02 | 9,207 | — | $0 | 9,207 | SEC↗ |
| BRUNK GERALD A | Director, 10% Owner | A Award deriv | 2023-10-31 | 2023-11-02 | 145,603 | — | $0 | 145,603 | SEC↗ |
| BRUNK GERALD A | Director, 10% Owner | A Award deriv | 2023-10-31 | 2023-11-02 | 114,945 | — | $0 | 114,945 | SEC↗ |
| Forbion Growth Sponsor FEAC I | 10% Owner | J Other deriv | 2023-10-31 | 2023-11-02 | 950,153 | — | $0 | 1,736,406 | SEC↗ |
| Forbion Growth Sponsor FEAC I | 10% Owner | J Other deriv | 2023-10-31 | 2023-11-02 | 54,634 | — | $0 | 786,253 | SEC↗ |
| BRUNK GERALD A | Director, 10% Owner | A Award | 2023-10-31 | 2023-11-02 | 44,647 | — | $0 | 44,647 | SEC↗ |
| BRUNK GERALD A | Director, 10% Owner | A Award | 2023-10-31 | 2023-11-02 | 348,686 | — | $0 | 348,686 | SEC↗ |
| BRUNK GERALD A | Director, 10% Owner | A Award | 2023-10-31 | 2023-11-02 | 83,816 | — | $0 | 83,816 | SEC↗ |
| BRUNK GERALD A | Director, 10% Owner | A Award | 2023-10-31 | 2023-11-02 | 1,341,790 | — | $0 | 1,341,790 | SEC↗ |
| BRUNK GERALD A | Director, 10% Owner | A Award | 2023-10-31 | 2023-11-02 | 1,077,386 | — | $0 | 1,077,386 | SEC↗ |
| BRUNK GERALD A | Director, 10% Owner | A Award | 2023-10-31 | 2023-11-02 | 152,974 | — | $0 | 152,974 | SEC↗ |
| Glickman Richard M | Director | A Award | 2023-10-31 | 2023-11-02 | 24,555 | — | $0 | 24,555 | SEC↗ |
| CHEUNG ANTHONY TZEYEW | Chief Technology Officer | A Award | 2023-10-31 | 2023-11-02 | 49,933 | — | $0 | 49,933 | SEC↗ |
| Forbion Growth Sponsor FEAC I | 10% Owner | J Other | 2023-10-31 | 2023-11-02 | 130,085 | — | $0 | 1,503,581 | SEC↗ |
| Forbion Growth Sponsor FEAC I | 10% Owner | J Other | 2023-10-31 | 2023-11-02 | 2,262,351 | — | $0 | 3,765,932 | SEC↗ |
| Sullivan James Crowley | Chief Scientific Officer | A Award deriv | 2023-07-07 | 2023-11-02 | 118,509 | — | $0 | 118,509 | SEC↗ |
| Hanson Jason David | Chief Executive Officer | A Award deriv | 2023-07-07 | 2023-11-02 | 512,826 | — | $0 | 512,826 | SEC↗ |
| CHEUNG ANTHONY TZEYEW | Chief Technology Officer | A Award deriv | 2023-07-07 | 2023-11-02 | 185,222 | — | $0 | 185,222 | SEC↗ |
| Nichols Alexander Julian | Pres. & Chief Operating Ofc. | A Award deriv | 2023-07-07 | 2023-11-02 | 101,924 | — | $0 | 101,924 | SEC↗ |
| Nichols Alexander Julian | Pres. & Chief Operating Ofc. | A Award deriv | 2023-02-18 | 2023-11-02 | 177,935 | — | $0 | 177,935 | SEC↗ |
| Sullivan James Crowley | Chief Scientific Officer | A Award deriv | 2022-03-18 | 2023-11-02 | 88,901 | — | $0 | 88,901 | SEC↗ |
| Glickman Richard M | Director | A Award deriv | 2021-08-20 | 2023-11-02 | 12,001 | — | $0 | 12,001 | SEC↗ |
| Glickman Richard M | Director | A Award deriv | 2021-08-20 | 2023-11-02 | 14,205 | — | $0 | 14,205 | SEC↗ |
| Hanson Jason David | Chief Executive Officer | A Award deriv | 2021-08-20 | 2023-11-02 | 10,906 | — | $0 | 10,906 | SEC↗ |
| Hanson Jason David | Chief Executive Officer | A Award deriv | 2021-08-20 | 2023-11-02 | 524,544 | — | $0 | 524,544 | SEC↗ |
| CHEUNG ANTHONY TZEYEW | Chief Technology Officer | A Award deriv | 2021-08-20 | 2023-11-02 | 2,255 | — | $0 | 2,255 | SEC↗ |
| CHEUNG ANTHONY TZEYEW | Chief Technology Officer | A Award deriv | 2021-08-20 | 2023-11-02 | 155,472 | — | $0 | 155,472 | SEC↗ |
| Glickman Richard M | Director | A Award deriv | 2020-12-14 | 2023-11-02 | 12,032 | — | $0 | 12,032 | SEC↗ |
| CHEUNG ANTHONY TZEYEW | Chief Technology Officer | A Award deriv | 2020-12-14 | 2023-11-02 | 1,266 | — | $0 | 1,266 | SEC↗ |
| Hanson Jason David | Chief Executive Officer | A Award deriv | 2019-07-30 | 2023-11-02 | 30,939 | — | $0 | 30,939 | SEC↗ |
| Hanson Jason David | Chief Executive Officer | A Award deriv | 2018-07-09 | 2023-11-02 | 137,051 | — | $0 | 137,051 | SEC↗ |
| Glickman Richard M | Director | A Award deriv | 2018-03-16 | 2023-11-02 | 4,123 | — | $0 | 4,123 | SEC↗ |
| CHEUNG ANTHONY TZEYEW | Chief Technology Officer | A Award deriv | 2018-03-16 | 2023-11-02 | 36,618 | — | $0 | 36,618 | SEC↗ |
| Glickman Richard M | Director | A Award deriv | 2017-06-15 | 2023-11-02 | 3,188 | — | $0 | 3,188 | SEC↗ |
| Glickman Richard M | Director | A Award deriv | 2016-01-11 | 2023-11-02 | 9,023 | — | $0 | 9,023 | SEC↗ |
| CHEUNG ANTHONY TZEYEW | Chief Technology Officer | A Award deriv | 2016-01-11 | 2023-11-02 | 22,860 | — | $0 | 22,860 | SEC↗ |
| Glickman Richard M | Director | A Award deriv | 2015-05-21 | 2023-11-02 | 11,189 | — | $0 | 11,189 | SEC↗ |
| CHEUNG ANTHONY TZEYEW | Chief Technology Officer | A Award deriv | 2015-05-21 | 2023-11-02 | 28,876 | — | $0 | 28,876 | SEC↗ |
| Glickman Richard M | Director | A Award deriv | 2013-12-04 | 2023-11-02 | 120 | — | $0 | 120 | SEC↗ |
| CHEUNG ANTHONY TZEYEW | Chief Technology Officer | A Award deriv | 2013-12-04 | 2023-11-02 | 52,940 | — | $0 | 52,940 | SEC↗ |